BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 78 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,784,000 | +177.0% | 33,763 | +221.2% | 0.37% | +189.9% |
| Q2 2020 | $644,000 | -40.4% | 10,511 | -44.7% | 0.13% | +25.2% |
| Q4 2019 | $1,081,000 | -46.0% | 18,991 | -49.2% | 0.10% | -31.8% |
| Q3 2019 | $2,001,000 | -57.2% | 37,391 | -52.3% | 0.15% | -54.8% |
| Q2 2019 | $4,677,000 | +7.2% | 78,335 | +12.0% | 0.33% | +5.4% |
| Q1 2019 | $4,361,000 | -99.7% | 69,964 | +159.2% | 0.32% | +140.2% |
| Q4 2018 | $1,635,897,000 | +23.6% | 26,995 | +19.3% | 0.13% | +55.3% |
| Q3 2018 | $1,323,980,000 | +45.0% | 22,636 | +11.2% | 0.08% | +28.8% |
| Q2 2018 | $913,260,000 | -39.0% | 20,358 | -39.7% | 0.07% | -41.1% |
| Q1 2018 | $1,497,805,000 | -29.4% | 33,780 | -31.0% | 0.11% | -32.1% |
| Q4 2017 | $2,121,090,000 | -22.8% | 48,952 | -17.1% | 0.16% | -29.5% |
| Q3 2017 | $2,748,262,000 | -2.7% | 59,077 | +3.6% | 0.23% | -10.3% |
| Q2 2017 | $2,823,753,000 | -13.1% | 57,034 | -3.8% | 0.26% | -18.2% |
| Q1 2017 | $3,248,435,000 | +22.9% | 59,278 | +24.9% | 0.32% | +7.4% |
| Q4 2016 | $2,643,578,000 | +233.2% | 47,461 | +173.2% | 0.30% | +241.4% |
| Q3 2016 | $793,425,000 | -15.6% | 17,373 | -26.2% | 0.09% | -32.0% |
| Q2 2016 | $939,588,000 | +11.4% | 23,525 | -2.9% | 0.13% | +8.5% |
| Q1 2016 | $843,236,000 | +202.9% | 24,217 | +273.8% | 0.12% | +181.0% |
| Q4 2015 | $278,403,000 | – | 6,479 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|